GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » Liabilities-to-Assets

Obio Technology (shanghai) (SHSE:688238) Liabilities-to-Assets : 0.26 (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Obio Technology (shanghai)'s Total Liabilities for the quarter that ended in Mar. 2025 was ¥571.9 Mil. Obio Technology (shanghai)'s Total Assets for the quarter that ended in Mar. 2025 was ¥2,194.4 Mil. Therefore, Obio Technology (shanghai)'s Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 was 0.26.


Obio Technology (shanghai) Liabilities-to-Assets Historical Data

The historical data trend for Obio Technology (shanghai)'s Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obio Technology (shanghai) Liabilities-to-Assets Chart

Obio Technology (shanghai) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.27 0.13 0.21 0.24

Obio Technology (shanghai) Quarterly Data
Jun19 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.21 0.24 0.26

Competitive Comparison of Obio Technology (shanghai)'s Liabilities-to-Assets

For the Biotechnology subindustry, Obio Technology (shanghai)'s Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obio Technology (shanghai)'s Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obio Technology (shanghai)'s Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Obio Technology (shanghai)'s Liabilities-to-Assets falls into.


;
;

Obio Technology (shanghai) Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Obio Technology (shanghai)'s Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Liabilities-to-Assets (A: Dec. 2024 )=Total Liabilities/Total Assets
=545.193/2284.741
=0.24

Obio Technology (shanghai)'s Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 is calculated as

Liabilities-to-Assets (Q: Mar. 2025 )=Total Liabilities/Total Assets
=571.888/2194.351
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Obio Technology (shanghai)  (SHSE:688238) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Obio Technology (shanghai) Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Obio Technology (shanghai) Business Description

Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201321
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines